CPRX [NASD]
Catalyst Pharmaceuticals, Inc.
Index- P/E26.66 EPS (ttm)0.61 Insider Own5.90% Shs Outstand103.32M Perf Week4.65%
Market Cap1.66B Forward P/E12.66 EPS next Y1.28 Insider Trans-35.74% Shs Float97.66M Perf Month-17.30%
Income66.90M PEG- EPS next Q0.20 Inst Own83.20% Short Float / Ratio10.43% / 3.62 Perf Quarter15.29%
Sales191.80M P/S8.63 EPS this Y-48.10% Inst Trans10.62% Short Interest10.19M Perf Half Y49.13%
Book/sh2.61 P/B6.21 EPS next Y75.82% ROA24.70% Target Price20.70 Perf Year187.92%
Cash/sh2.51 P/C6.46 EPS next 5Y- ROE28.50% 52W Range5.61 - 22.11 Perf YTD-12.85%
Dividend- P/FCF- EPS past 5Y29.80% ROI19.00% 52W High-26.68% Beta1.18
Dividend %- Quick Ratio6.00 Sales past 5Y- Gross Margin84.10% 52W Low188.95% ATR1.14
Employees76 Current Ratio6.20 Sales Q/Q58.90% Oper. Margin43.70% RSI (14)44.40 Volatility4.29% 7.40%
OptionableYes Debt/Eq0.00 EPS Q/Q112.10% Profit Margin34.90% Rel Volume0.81 Prev Close15.87
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout0.00% Avg Volume2.81M Price16.21
Recom2.20 SMA20-8.84% SMA50-8.30% SMA20029.38% Volume2,271,423 Change2.14%
Aug-24-22Downgrade ROTH Capital Buy → Neutral $10 → $15.50
Sep-21-18Initiated Cantor Fitzgerald Overweight
Sep-07-18Resumed Piper Jaffray Overweight
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Sep-24-13Initiated Maxim Group Buy $4
Show Previous Ratings
Feb-07-23 08:03AM
Feb-06-23 05:50PM
Feb-03-23 09:00AM
Jan-30-23 05:50PM
Jan-26-23 09:22AM
08:03AM Loading…
Jan-25-23 08:03AM
02:54AM
Jan-23-23 01:25PM
12:45PM
09:00AM
08:30AM
08:03AM
Jan-19-23 06:00PM
Jan-10-23 09:00AM
Jan-05-23 08:30AM
11:58PM Loading…
Dec-28-22 11:58PM
10:15PM
Dec-20-22 08:30AM
Dec-19-22 04:10PM
Dec-16-22 04:30PM
08:09AM
Dec-14-22 09:00AM
Dec-13-22 09:35AM
Dec-12-22 03:44PM
Dec-09-22 11:30AM
Dec-02-22 08:30AM
Nov-28-22 10:23AM
Nov-14-22 12:45PM
09:40AM
08:30AM
09:49AM Loading…
Nov-11-22 09:49AM
Nov-09-22 05:35PM
04:11PM
Nov-07-22 08:03AM
Nov-04-22 04:46AM
Oct-25-22 08:03AM
Oct-21-22 09:30AM
Oct-19-22 09:40AM
Oct-18-22 07:02AM
Oct-03-22 09:40AM
Sep-29-22 11:18AM
Sep-28-22 10:30AM
Sep-15-22 12:45PM
12:00PM
09:40AM
Sep-13-22 05:53PM
Sep-12-22 07:30PM
08:30AM
Sep-09-22 08:45AM
08:03AM
Sep-08-22 11:30AM
09:35AM
Sep-05-22 01:46PM
Aug-26-22 12:45PM
12:00PM
09:40AM
08:30AM
Aug-24-22 08:03AM
Aug-23-22 10:53AM
Aug-09-22 06:35PM
04:25PM
Jul-26-22 08:03AM
Jul-14-22 06:01AM
Jul-12-22 06:00AM
Jun-25-22 08:15AM
Jun-09-22 11:30AM
Jun-04-22 11:07AM
May-17-22 08:03AM
May-11-22 06:05AM
May-10-22 05:25PM
04:11PM
May-09-22 05:45PM
Apr-25-22 08:03AM
Apr-05-22 06:41PM
Mar-29-22 05:15PM
Mar-16-22 05:45PM
04:21PM
09:40AM
Mar-11-22 08:03AM
Mar-09-22 03:00PM
09:45AM
Mar-08-22 08:03AM
Mar-03-22 09:20AM
Mar-02-22 08:03AM
Feb-28-22 10:00AM
08:50AM
Feb-24-22 08:03AM
Feb-17-22 08:03AM
Feb-15-22 10:41AM
Feb-11-22 08:50AM
Feb-10-22 10:00AM
09:40AM
Feb-08-22 09:49AM
Feb-07-22 08:03AM
Feb-03-22 08:03AM
Jan-28-22 01:46PM
Jan-16-22 07:05AM
Jan-10-22 08:03AM
Jan-05-22 07:25AM
Jan-04-22 07:30AM
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENKHAUS DONALD ADirectorJan 24Option Exercise0.7950,00039,500329,000Jan 27 04:30 PM
O'Keeffe Charles BDirectorJan 24Option Exercise0.7950,00039,500616,391Jan 27 04:30 PM
INGENITO GARYChief Medical OfficerDec 06Sale16.855,91899,71830,802Dec 08 05:03 PM
Miller SteveChief Operating OfficerNov 23Sale17.3420,000346,740553,791Nov 23 05:01 PM
COELHO PHILIP HDirectorNov 23Sale17.459,999174,483149,553Nov 23 05:00 PM
GRANDE ALICIAVP, Treasurer and CFONov 22Sale16.53120,0001,983,24027,442Nov 23 05:02 PM
COELHO PHILIP HDirectorNov 22Sale17.3020,001346,097159,552Nov 23 05:00 PM
MCENANY PATRICK JPresident and CEONov 21Option Exercise2.24150,000336,0004,052,606Nov 22 05:00 PM
Miller SteveChief Operating OfficerNov 21Sale15.2880,0001,222,080573,791Nov 23 05:01 PM
COELHO PHILIP HDirectorNov 21Sale15.2370,0001,066,170179,553Nov 23 05:00 PM
MCENANY PATRICK JPresident and CEONov 21Sale15.33150,0002,299,8003,902,606Nov 22 05:00 PM
MCENANY PATRICK JPresident and CEONov 18Option Exercise2.24350,000784,0004,252,606Nov 22 05:00 PM
MCENANY PATRICK JPresident and CEONov 18Sale15.62350,0005,467,7003,902,606Nov 22 05:00 PM
GRANDE ALICIAVP, Treasurer and CFONov 15Sale15.7760,000946,080147,442Nov 17 05:00 PM
Elsbernd BrianChief Compliance/Legal OfficerNov 14Option Exercise1.45105,000151,850116,096Nov 15 05:00 PM
Del Carmen JeffreyChief Commercial OfficerNov 11Option Exercise2.78139,017385,798120,000Nov 15 05:00 PM
Sundaram PreethiChief Strategy OfficerNov 11Option Exercise5.4956,786311,75556,786Nov 15 05:01 PM
Elsbernd BrianChief Compliance/Legal OfficerNov 11Sale16.2314,666238,10311,096Nov 15 05:00 PM
Sundaram PreethiChief Strategy OfficerNov 11Sale16.3856,786929,8710Nov 15 05:01 PM
Del Carmen JeffreyChief Commercial OfficerNov 11Sale16.12139,0172,241,3820Nov 15 05:00 PM
DENKHAUS DONALD ADirectorNov 11Sale16.5920,000331,880277,666Nov 15 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOSep 23Sale11.9060,000713,940207,442Sep 26 05:01 PM
GRANDE ALICIAVP, Treasurer and CFOSep 16Sale13.5090,0001,214,640267,442Sep 20 05:00 PM
Sundaram PreethiChief Strategy OfficerSep 15Option Exercise5.4918,21499,99518,214Sep 16 05:01 PM
Sundaram PreethiChief Strategy OfficerSep 15Sale14.4918,214263,9210Sep 16 05:01 PM
INGENITO GARYChief Medical & Reg. OfficerSep 14Option Exercise4.40143,000628,870110,053Sep 16 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOSep 14Sale15.5750,000778,650357,442Sep 16 05:00 PM
INGENITO GARYChief Medical & Reg. OfficerSep 14Sale15.67143,0002,241,45922,053Sep 16 05:00 PM
DENKHAUS DONALD ADirectorSep 14Sale15.3420,000306,800297,666Sep 15 05:02 PM
MCENANY PATRICK JPresident and CEOSep 14Sale15.41946,84614,594,6843,902,606Sep 15 05:01 PM
COELHO PHILIP HDirectorSep 14Sale15.7520,000315,000249,553Sep 15 05:00 PM
Miller SteveChief Operating OfficerSep 13Sale16.90107,9331,824,367653,791Sep 15 05:01 PM
MCENANY PATRICK JPresident and CEOSep 13Sale15.3380,7651,238,0474,849,452Sep 15 05:01 PM
COELHO PHILIP HDirectorSep 13Sale15.7010,000157,000269,553Sep 15 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOAug 29Sale14.2057,000809,560407,442Aug 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOAug 26Sale14.4011,095159,768464,442Aug 30 05:00 PM
Daly Richard JDirectorAug 24Option Exercise2.5340,000101,20092,666Aug 26 05:01 PM
Tierney David SDirectorAug 22Option Exercise2.5320,00050,600328,207Aug 23 05:01 PM
Tierney David SDirectorAug 22Sale14.1620,000283,180308,207Aug 23 05:01 PM
MCENANY PATRICK JPresident and CEOAug 19Option Exercise2.53125,000316,2505,055,217Aug 19 05:02 PM
MCENANY PATRICK JPresident and CEOAug 19Sale14.10125,0001,762,4254,930,217Aug 19 05:02 PM
GRANDE ALICIAVP, Treasurer and CFOAug 18Option Exercise2.5319,25948,725494,796Aug 19 05:02 PM
Miller SteveChief Operating OfficerAug 18Option Exercise2.53150,000379,500880,299Aug 19 05:03 PM
O'Keeffe Charles BDirectorAug 18Option Exercise2.5340,000101,200653,042Aug 19 05:03 PM
MCENANY PATRICK JPresident and CEOAug 18Option Exercise2.53175,000442,7504,980,217Aug 19 05:02 PM
MCENANY PATRICK JPresident and CEOAug 18Sale13.94175,0002,440,3504,930,217Aug 19 05:02 PM
Miller SteveChief Operating OfficerAug 18Sale13.53150,0002,029,922761,724Aug 19 05:03 PM
GRANDE ALICIAVP, Treasurer and CFOAug 18Sale13.7019,259263,848475,537Aug 19 05:02 PM
GRANDE ALICIAVP, Treasurer and CFOAug 17Option Exercise2.53130,741330,775574,853Aug 19 05:02 PM
COELHO PHILIP HDirectorAug 17Option Exercise2.5340,000101,200279,553Aug 19 05:02 PM
GRANDE ALICIAVP, Treasurer and CFOAug 17Sale13.86130,7411,811,635475,537Aug 19 05:02 PM
INGENITO GARYChief Medical & Reg. OfficerJun 22Option Exercise4.136,15225,40828,205Jun 23 05:02 PM
INGENITO GARYChief Medical & Reg. OfficerJun 22Sale6.616,15240,64622,053Jun 23 05:02 PM
INGENITO GARYChief Medical & Reg. OfficerJun 21Option Exercise4.13143,848594,092165,901Jun 23 05:02 PM
INGENITO GARYChief Medical & Reg. OfficerJun 21Sale6.59143,848948,67822,053Jun 23 05:02 PM
Tierney David SDirectorMay 20Option Exercise2.5320,00050,600328,207May 24 04:30 PM